AppMed
AppMed is dedicated to providing healthcare professionals with a digital platform that optimizes medication treatment through personalized approaches. Their solutions include drug dosage modeling, remote evaluation of clinical responses, and adherence monitoring, aiming to enhance health outcomes and streamline treatment processes. The company focuses on disease-specific solutions in areas such as ADHD, immunosuppression, and opioid pain management, with a mission to transform healthcare through innovative, patient-centric, data-driven solutions.
Industries
Nr. of Employees
small (1-50)
Patents
System and method for monitoring and identifying posology efficacy for an an individual
US-11185282-B2
View Details
System and method for monitoring and identifying posology efficacy for an an individual
US-11185282-B2
View DetailsProducts
Web-based medication optimization platform
A disease-specific, multi-user web application that aggregates patient data, supports model-informed dosing, hosts validated digital questionnaires, and exports reports for EMR integration.
Smart medication dispensing device
A connected dispensing device that delivers medications in solid form, tracks adherence, issues alerts, and synchronizes dosing with control software over cellular networks.
Centralized laboratory analysis service
Laboratory testing service for therapeutic drug monitoring and biomarker assays performed on samples collected remotely and shipped to a centralized, ISO-accredited facility.
Web-based medication optimization platform
A disease-specific, multi-user web application that aggregates patient data, supports model-informed dosing, hosts validated digital questionnaires, and exports reports for EMR integration.
Smart medication dispensing device
A connected dispensing device that delivers medications in solid form, tracks adherence, issues alerts, and synchronizes dosing with control software over cellular networks.
Centralized laboratory analysis service
Laboratory testing service for therapeutic drug monitoring and biomarker assays performed on samples collected remotely and shipped to a centralized, ISO-accredited facility.
Services
Provision and configuration of a web-based, disease-specific platform that consolidates patient data, supports clinician collaboration, and enables dosing optimisation workflows.
End-to-end service including at-home specimen collection devices, sample shipping to a centralized accredited laboratory, laboratory analysis, and automatic integration of results into the digital platform.
Provision of smart medication dispensing devices and associated monitoring software that enable real-time adherence tracking, alerts, and remote dose synchronization.
Support for condition-specific clinical research including data capture, analytics, and integration of model-informed dosing and real-world evidence methodologies.
Provision and configuration of a web-based, disease-specific platform that consolidates patient data, supports clinician collaboration, and enables dosing optimisation workflows.
End-to-end service including at-home specimen collection devices, sample shipping to a centralized accredited laboratory, laboratory analysis, and automatic integration of results into the digital platform.
Provision of smart medication dispensing devices and associated monitoring software that enable real-time adherence tracking, alerts, and remote dose synchronization.
Support for condition-specific clinical research including data capture, analytics, and integration of model-informed dosing and real-world evidence methodologies.
Expertise Areas
- Model-informed precision dosing
- Remote therapeutic drug monitoring
- Digital health platform development
- Medication adherence systems
Key Technologies
- Model-Informed Precision Dosing (MIPD)
- Web-based multi-platform applications
- Remote biomarker collection and centralized laboratory analysis
- Digital patient-reported outcome questionnaires
News & Updates
In July 2024, Thess Corporate and AppMed entered into a reciprocal marketing agreement for technological innovations in North America and Europe.
System and Method for Identifying Optimal Posology for an Individual.
In July 2024, Thess Corporate and AppMed entered into a reciprocal marketing agreement for technological innovations in North America and Europe.
System and Method for Identifying Optimal Posology for an Individual.